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GBM generally exhibit high expression levels of transforming growth factor  (TGFβ ), its receptors and its target, 
tenascin.  Cancer cells in which TGFβ  signaling is compromised exhibit ineffective classical homologous combination 
and non-homologuos end-joining.  As a consequence, DNA repair is primarily executed by an error-prone DNA repair 
pathway called alternative end-joining (altEJ), that is highly dependent on poly(ADP-ribose)polymerase (PARP).  We 
determined that  chronic TGFβ and altEJ transcriptional signatures are anti-corrleated (Pearson’s correlation 
coefficient = -0.88, p<10-16) in GBM TCGA. Patients whose tumors exhibit the low TGFβ/high altEJ profile experience 
longer progression free survival (p<0.003) and overall survival (p<0.02) compared to those whose tumors have a high 
TGFβ/low altEJ profile.  Preclinical data show that TGFβ  inhibitor treatment of TGFβ competent GBM cell lines impairs 
classical DDR, thus forcing the cells to resort to altEJ and sensitizes to radiotherapy and PARP inhibition, providing 
strong rationale for translational studies.
